AliveCor
We believe some of the most transformative businesses of the next decade will be in health and life sciences. We are particularly interested in investments that reflect the convergence of the physical, digital, virtual, and biological world. Areas of specific focus include longevity, patient-enabled health management, and synthetic biology as it impacts information technology. The intelligent collection and synthesis of data will be a driving force behind advances in those fields.
All Health & Life Sciences
Aqtual
Bionaut Labs
CareSignal
EXIT: M&A
Colossal
Curebase
Deciduous Therapeutics
Deep Longevity
EXIT: IPO
Discure
Docbot
Elevian
eXo
Form Bio
Fountain Therapeutic Services
Gallant Pet
Gameto
Holoclara
Human in Motion Robotics
Immunis Biomedical
Insilico Medicine
iota Biosciences
EXIT: M&A
Iviva Medical
KeyCare
Matrisome Bio
Meru Health
Omeat
Openwater
OURA Health
EXIT: M&A
Proprio
Seed
SeQureDX
Solarea Bio
Stealth FoodTech Company
Stealth Longevity Company
Stealth Oral Health Company
Stuff That Works
Switch Therapeutics
Symbiome
Syntis Bio
Viome
Technological developments such as AI, Blockchain, Sensors, VR, and 3D printing, are accelerating at exponential rates and revolutionizing human productivity. BOLD believes the convergence of these exponential technologies will enable entrepreneurs to create better, more personalized products and services at increasingly faster speeds and dramatically lower costs. By democratizing access, these BOLD entrepreneurs and their companies will transform every industry while uplifting humanity.